PE20160855A1 - Quinazolin-thf-aminas como inhibidores de pde1 - Google Patents
Quinazolin-thf-aminas como inhibidores de pde1Info
- Publication number
- PE20160855A1 PE20160855A1 PE2016000825A PE2016000825A PE20160855A1 PE 20160855 A1 PE20160855 A1 PE 20160855A1 PE 2016000825 A PE2016000825 A PE 2016000825A PE 2016000825 A PE2016000825 A PE 2016000825A PE 20160855 A1 PE20160855 A1 PE 20160855A1
- Authority
- PE
- Peru
- Prior art keywords
- quinazolin
- ethyl
- methyl
- amine
- thf
- Prior art date
Links
- 229940121836 Phosphodiesterase 1 inhibitor Drugs 0.000 title 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000000980 schizophrenia Diseases 0.000 abstract 2
- KZVGDSXTLLMZGO-UHFFFAOYSA-N 7,8-dimethoxy-N-(oxolan-3-yl)quinazolin-4-amine Chemical compound COC1=CC=C2C(=NC=NC2=C1OC)NC1COCC1 KZVGDSXTLLMZGO-UHFFFAOYSA-N 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000028698 Cognitive impairment Diseases 0.000 abstract 1
- 101001117089 Drosophila melanogaster Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- RZWCBJXWNBLCCY-DOMZBBRYSA-N N-[(2S,3R)-2-cyclopropyloxolan-3-yl]-7,8-dimethoxyquinazolin-4-amine Chemical compound C1(CC1)[C@@H]1OCC[C@H]1NC1=NC=NC2=C(C(=CC=C12)OC)OC RZWCBJXWNBLCCY-DOMZBBRYSA-N 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- -1 quinazolin-amine derivative compound Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Referida a un compuesto derivado de quinazolin-amina de formula (I), donde R1 es H o alquilo C1-C3; R2 es H o alquilo C1-C3; R3 es H, metilo o etilo; R4 es H, OH, metoxi o etoxi; R5, R6 y R7 son H; R8 es H, metilo, etilo, ciclopropilo; R9 es es H, metilo o etilo. Son compuestos preferidos: 7,8-dimetoxi-N-(tetrahidrofuran-3il)quinazolin-4-amina, trans-N-(-2-ciclopropiltetrahidrofuran-3-il)-7,8-dimetoxiquinazolin-4-amina, entre otros. Dichos compuestos actuan como inhibidores de enzimas PDE1, siendo utiles para el tratamiento del trastorno por deficit de atencion con hiperactividad (TDAH), esquizofrenia o deterioro cognitivo asociado con la esquizofrenia, entre otros
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201300707 | 2013-12-19 | ||
| DKPA201400249 | 2014-05-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20160855A1 true PE20160855A1 (es) | 2016-09-23 |
Family
ID=52350066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2016000825A PE20160855A1 (es) | 2013-12-19 | 2014-12-18 | Quinazolin-thf-aminas como inhibidores de pde1 |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US9701665B2 (es) |
| EP (1) | EP3083607B1 (es) |
| JP (1) | JP6419832B2 (es) |
| KR (1) | KR20160098269A (es) |
| CN (1) | CN105829300B (es) |
| AP (1) | AP2016009293A0 (es) |
| AU (1) | AU2014368601B2 (es) |
| BR (1) | BR112016013946A8 (es) |
| CA (1) | CA2933299A1 (es) |
| CL (1) | CL2016001488A1 (es) |
| CR (1) | CR20160282A (es) |
| DO (1) | DOP2016000152A (es) |
| EA (1) | EA201691108A1 (es) |
| EC (1) | ECSP16061208A (es) |
| ES (1) | ES2728079T3 (es) |
| GE (1) | GEP201706764B (es) |
| IL (1) | IL246230A0 (es) |
| MX (1) | MX2016007945A (es) |
| PE (1) | PE20160855A1 (es) |
| PH (1) | PH12016501173A1 (es) |
| RU (1) | RU2016125315A (es) |
| SG (1) | SG11201604936TA (es) |
| SV (1) | SV2016005220A (es) |
| TN (1) | TN2016000239A1 (es) |
| TW (1) | TW201609713A (es) |
| WO (1) | WO2015091805A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201609713A (zh) * | 2013-12-19 | 2016-03-16 | Ｈ 朗德貝克公司 | 作爲ｐｄｅ１抑制劑之喹唑啉－ｔｈｆ－胺 |
| EP3126354B1 (en) | 2014-04-04 | 2020-01-22 | H. Lundbeck A/S | Halogenated quinazolin-thf-amines as pde1 inhibitors |
| TWI729109B (zh) * | 2016-04-12 | 2021-06-01 | 丹麥商Ｈ 朗德貝克公司 | 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮 |
| KR102590848B1 (ko) | 2016-12-28 | 2023-10-19 | 다트 뉴로사이언스, 엘엘씨 | Pde2 억제제로서 치환된 피라졸로피리미디논 화합물 |
| ES2902365T3 (es) | 2017-11-27 | 2022-03-28 | Dart Neuroscience Llc | Compuestos de furanopirimidina sustituidos como inhibidores de PDE1 |
| AU2019275453B2 (en) | 2018-05-25 | 2023-12-21 | Intra-Cellular Therapies, Inc. | Organic compounds |
| JP7706375B2 (ja) | 2019-04-12 | 2025-07-11 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005511500A (ja) * | 2001-08-31 | 2005-04-28 | ザ ロックフェラー ユニバーシティー | 脳におけるホスホジエステラーゼ活性およびホスホジエステラーゼ１ｂ媒介シグナル伝達の調節 |
| ZA200507228B (en) * | 2003-04-01 | 2007-03-28 | Applied Research Systems | Inhibitors of phosphodiesterases in infertility |
| JP2007535560A (ja) * | 2004-04-28 | 2007-12-06 | シーブイ・セラピューティクス・インコーポレイテッド | Ａ１アデノシンレセプターアンタゴニスト |
| EP1940819A1 (en) * | 2005-08-16 | 2008-07-09 | Memory Pharmaceuticals Corporation | Phosphodiesterase 10 inhibitors |
| EP1996587A1 (en) | 2006-02-23 | 2008-12-03 | Pfizer Products Incorporated | Substituted quinazolines as pde10 inhibitors |
| WO2009137465A2 (en) * | 2008-05-05 | 2009-11-12 | University Of Rochester | Methods and compositions for the treatment or prevention of pathological cardiac remodeling and heart failure |
| WO2010132127A1 (en) * | 2009-05-13 | 2010-11-18 | Intra-Cellular Therapies, Inc. | Organic compounds |
| JP2013505909A (ja) * | 2009-09-24 | 2013-02-21 | ビーエーエスエフ ソシエタス・ヨーロピア | 無脊椎動物害虫を駆除するためのアミノキナゾリン化合物 |
| TW201609713A (zh) | 2013-12-19 | 2016-03-16 | Ｈ 朗德貝克公司 | 作爲ｐｄｅ１抑制劑之喹唑啉－ｔｈｆ－胺 |
-
2014
- 2014-12-01 TW TW103141539A patent/TW201609713A/zh unknown
- 2014-12-18 JP JP2016541407A patent/JP6419832B2/ja not_active Expired - Fee Related
- 2014-12-18 ES ES14827431T patent/ES2728079T3/es active Active
- 2014-12-18 PE PE2016000825A patent/PE20160855A1/es not_active Application Discontinuation
- 2014-12-18 KR KR1020167016258A patent/KR20160098269A/ko not_active Withdrawn
- 2014-12-18 BR BR112016013946A patent/BR112016013946A8/pt not_active IP Right Cessation
- 2014-12-18 WO PCT/EP2014/078475 patent/WO2015091805A1/en not_active Ceased
- 2014-12-18 TN TN2016000239A patent/TN2016000239A1/en unknown
- 2014-12-18 US US15/105,647 patent/US9701665B2/en not_active Expired - Fee Related
- 2014-12-18 AP AP2016009293A patent/AP2016009293A0/en unknown
- 2014-12-18 CR CR20160282A patent/CR20160282A/es unknown
- 2014-12-18 SG SG11201604936TA patent/SG11201604936TA/en unknown
- 2014-12-18 EP EP14827431.9A patent/EP3083607B1/en active Active
- 2014-12-18 AU AU2014368601A patent/AU2014368601B2/en not_active Expired - Fee Related
- 2014-12-18 CA CA2933299A patent/CA2933299A1/en not_active Abandoned
- 2014-12-18 GE GEAP201414180A patent/GEP201706764B/en unknown
- 2014-12-18 CN CN201480068495.XA patent/CN105829300B/zh not_active Expired - Fee Related
- 2014-12-18 US US14/574,425 patent/US20150175584A1/en not_active Abandoned
- 2014-12-18 RU RU2016125315A patent/RU2016125315A/ru unknown
- 2014-12-18 MX MX2016007945A patent/MX2016007945A/es unknown
- 2014-12-18 EA EA201691108A patent/EA201691108A1/ru unknown
-
2016
- 2016-06-14 CL CL2016001488A patent/CL2016001488A1/es unknown
- 2016-06-15 IL IL246230A patent/IL246230A0/en not_active IP Right Cessation
- 2016-06-15 SV SV2016005220A patent/SV2016005220A/es unknown
- 2016-06-16 PH PH12016501173A patent/PH12016501173A1/en unknown
- 2016-06-17 DO DO2016000152A patent/DOP2016000152A/es unknown
- 2016-07-18 EC ECIEPI201661208A patent/ECSP16061208A/es unknown
-
2017
- 2017-06-05 US US15/614,104 patent/US10030007B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20160855A1 (es) | Quinazolin-thf-aminas como inhibidores de pde1 | |
| PE20200387A1 (es) | Proceso novedoso para la elaboracion de compuestos para su uso en el tratamiento del cancer | |
| PH12017501016B1 (en) | Triazolopyrimidine compounds and uses thereof | |
| CU24408B1 (es) | Compuestos de dihidroisoquinolinona sustituida | |
| PE20180117A1 (es) | Inhibidores de indolamina-2,3-dioxigenasa para el tratamiento de cancer | |
| UY35908A (es) | Moduladores de tetrahidropiridopirazinas de gpr6 | |
| CR20150192A (es) | Moduladores de quinolinilo unidos a fenilo de ror-gamma-t | |
| PE20150966A1 (es) | Compuestos heteroaromaticos y su uso como ligandos d1 de dopamina | |
| PE20142456A1 (es) | COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks | |
| DOP2015000289A (es) | Compuestos de 3,4-dihidroisoquinolin-2(1h)-ilo | |
| MX369467B (es) | Procedimiento para la preparación de (4s)-4-(4-ciano-2-metoxifenil )-5-etoxi-2,8-dimetil-1,4-dihidro-1,6-naftiridin-3-carbox-amida y su purificación para su uso como principio activo farmacéutico. | |
| MX2015007925A (es) | Nucleosidos sustituidos, nucleotidos y analogos de los mismos. | |
| ECSP13012958A (es) | Inhibidores de benzodioxano de la producción de leucotrieno. | |
| UY33199A (es) | 5-alquinil-pirimidinas. | |
| CR20170118A (es) | Derivados espirodiamina como inhibidores de la aldosterona sintasa | |
| PE20180024A1 (es) | Triazolopirazinonas como inhibidores de pde1 | |
| CU20140072A7 (es) | Derivados de dihidro-oxazina y dihidro-pirido-oxazina | |
| ES2559857T3 (es) | Nuevos inhibidores de galactósido de galectinas | |
| CO2017001178A2 (es) | Derivado de piridona que tiene un grupo tetrahidropiranil metilo | |
| CU24263B1 (es) | Derivados de imidazopiridazinas inhibidores de quinasa akt, útiles para el tratamiento del cáncer | |
| EA201590561A1 (ru) | Пролекарства аминохиназолинового ингибитора киназы | |
| PE20151748A1 (es) | Inhibidores de bace1 | |
| CO2017001506A2 (es) | Compuestos novedosos de pirimidina sustituidos | |
| ECSP17010238A (es) | Compuestos novedosos de pirimidina sustituidos | |
| JO3143B1 (ar) | مركبات تتراهيدرو بيرولو ثيازين |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |